It is suggested that HLA-B molecules have a superior impact on the outcome of several infectious diseases, inflammatory conditions, autoimmune diseases and malignancies compared to HLA-A molecules, for reasons that remain not well understood. This evidence concerns the gene HLA-A and infectious disease.